Standard Chemical & Pharmaceutical Co. Ltd.

TWSE:1720 Stock Report

Market Cap: NT$12.9b

Standard Chemical & Pharmaceutical Past Earnings Performance

Past criteria checks 3/6

Standard Chemical & Pharmaceutical has been growing earnings at an average annual rate of 18.6%, while the Pharmaceuticals industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 11.9% per year. Standard Chemical & Pharmaceutical's return on equity is 15%, and it has net margins of 13.8%.

Key information

18.6%

Earnings growth rate

18.6%

EPS growth rate

Pharmaceuticals Industry Growth18.5%
Revenue growth rate11.9%
Return on equity15.0%
Net Margin13.8%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

Jul 14
Standard Chemical & Pharmaceutical (TWSE:1720) Will Pay A Larger Dividend Than Last Year At NT$2.70

If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late

Apr 13
If You Like EPS Growth Then Check Out Standard Chem & Pharm (TPE:1720) Before It's Too Late

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Mar 14
A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Does Standard Chem & Pharm (TPE:1720) Have A Healthy Balance Sheet?

Mar 01
Does Standard Chem & Pharm (TPE:1720) Have A Healthy Balance Sheet?

Should Standard Chem & Pharm (TPE:1720) Be Disappointed With Their 11% Profit?

Feb 16
Should Standard Chem & Pharm (TPE:1720) Be Disappointed With Their 11% Profit?

Is Standard Chem & Pharm CO., LTD.'s (TPE:1720) 4.3% Dividend Worth Your Time?

Feb 03
Is Standard Chem & Pharm CO., LTD.'s (TPE:1720) 4.3% Dividend Worth Your Time?

Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Jan 19
Standard Chem & Pharm CO., LTD.'s (TPE:1720) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today

Jan 04
Here's Why I Think Standard Chem & Pharm (TPE:1720) Might Deserve Your Attention Today

Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?

Dec 22
Is Standard Chem & Pharm CO., LTD. (TPE:1720) Popular Amongst Insiders?

A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Dec 08
A Look At The Fair Value Of Standard Chem & Pharm CO., LTD. (TPE:1720)

Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly

Nov 26
Standard Chem & Pharm (TPE:1720) Seems To Use Debt Rather Sparingly

Revenue & Expenses Breakdown

How Standard Chemical & Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TWSE:1720 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 246,3608771,225270
31 Dec 236,2408351,200266
30 Sep 236,2318481,148252
30 Jun 236,1358631,174246
31 Mar 236,1078531,151250
31 Dec 225,8518151,117252
30 Sep 225,501813499256
30 Jun 225,072734988249
31 Mar 224,740672970243
31 Dec 214,604707949242
30 Sep 214,489694980237
30 Jun 214,413649983239
31 Mar 214,372612973233
31 Dec 204,305524986227
30 Sep 204,219461962220
30 Jun 204,223455975224
31 Mar 204,125425979225
31 Dec 193,937376968226
30 Sep 193,905374981229
30 Jun 193,769383966217
31 Mar 193,656383955216
31 Dec 183,573374933225
30 Sep 183,480329927228
30 Jun 183,624366951236
31 Mar 183,702367942248
31 Dec 173,849363968240
30 Sep 173,898393942252
30 Jun 173,761347918248
31 Mar 173,725319935243
31 Dec 163,674340917241
30 Sep 163,635338931250
30 Jun 163,529323918247
31 Mar 163,374325876238
31 Dec 153,321348873239
30 Sep 153,280345890221
30 Jun 153,275349866233
31 Mar 153,304381853239
31 Dec 143,296374828243
30 Sep 143,203334803253
30 Jun 143,125292797243
31 Mar 143,069277823235
31 Dec 133,054299806226
30 Sep 133,207331809218

Quality Earnings: 1720 has high quality earnings.

Growing Profit Margin: 1720's current net profit margins (13.8%) are lower than last year (14%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 1720's earnings have grown by 18.6% per year over the past 5 years.

Accelerating Growth: 1720's earnings growth over the past year (2.8%) is below its 5-year average (18.6% per year).

Earnings vs Industry: 1720 earnings growth over the past year (2.8%) exceeded the Pharmaceuticals industry 2.8%.


Return on Equity

High ROE: 1720's Return on Equity (15%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.